論文

国際誌
2021年

Extracranial-intracranial high-flow bypass as a rescue therapy for incomplete cerebral aneurysm occlusion after flow diversion: A case report.

Surgical neurology international
  • Tomoya Kamide
  • ,
  • Kouichi Misaki
  • ,
  • Takehiro Uno
  • ,
  • Akifumi Yoshikawa
  • ,
  • Naoyuki Uchiyama
  • ,
  • Mitsutoshi Nakada

12
開始ページ
57
終了ページ
57
記述言語
英語
掲載種別
DOI
10.25259/SNI_836_2020

Background: Excellent treatment outcomes using a pipeline embolization device (PED) have been reported. However, several limitations exist. For example, patients must receive antiplatelet therapy for at least several months, and few alternative treatments exist except for inserting additional flow diverter stents in cases where aneurysm obliteration is not obtained. Case Description: A 67-year-old female suffered from an asymptomatic large aneurysm of the left paraclinoid internal carotid artery (ICA). She underwent endovascular coil embolization, but coil compaction was confirmed at 2-year follow-up. A PED was inserted as an additional treatment. Unfortunately, the patient was required to discontinue antiplatelet therapy to undergo orthopedic surgery for her severe osteoarthritis of the knee. However, surveillance imaging performed 2 years after insertion of the PED revealed persistent filling into the aneurysm, and we could not stop the antiplatelet therapy to proceed with orthopedic surgery. Therefore, we performed ICA trapping with extracranial-intracranial high-flow bypass to cease antiplatelet therapy promptly. Antiplatelet therapy was completed 3 months after the rescue surgery, and the patient underwent orthopedic surgery. Conclusion: The authors describe a case of failure of complete obliteration after treatment using a PED, which required cessation of antiplatelet therapy to receive orthopedic surgery. Although safety and efficacy of PED treatment have been reported, we must consider the possibility of other diseases requiring discontinuation of antiplatelet therapy after PED embolization.

リンク情報
DOI
https://doi.org/10.25259/SNI_836_2020
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/33654560
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911044
ID情報
  • DOI : 10.25259/SNI_836_2020
  • PubMed ID : 33654560
  • PubMed Central 記事ID : PMC7911044

エクスポート
BibTeX RIS